0001209191-23-053937.txt : 20231031 0001209191-23-053937.hdr.sgml : 20231031 20231031161024 ACCESSION NUMBER: 0001209191-23-053937 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231028 FILED AS OF DATE: 20231031 DATE AS OF CHANGE: 20231031 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Martin Daniel C. CENTRAL INDEX KEY: 0001752827 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38219 FILM NUMBER: 231364633 MAIL ADDRESS: STREET 1: C/O DECIPHERA PHARMACEUTICALS, INC. STREET 2: 200 SMITH STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Deciphera Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001654151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200299725 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 SMITH STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-209-6400 MAIL ADDRESS: STREET 1: 200 SMITH STREET CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Deciphera Pharmaceuticals, LLC DATE OF NAME CHANGE: 20150928 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-10-28 0 0001654151 Deciphera Pharmaceuticals, Inc. DCPH 0001752827 Martin Daniel C. C/O DECIPHERA PHARMACEUTICALS, INC. 200 SMITH STREET WALTHAM MA 02451 0 1 0 0 Chief Commercial Officer 0 Common Stock 2023-10-28 4 A 0 5576 A 64291 D Common Stock 2023-10-30 4 S 0 1407 12.0176 D 62884 D On February 15, 2023, the Reporting Person was granted restricted stock units ("RSUs"), which vest upon the satisfaction of three performance criteria. On October 28, 2023, the Issuer's Compensation Committee confirmed that performance criteria two had been met, resulting in the vesting of 5,576 RSUs. Includes 302 shares previously acquired under the Issuer's 2017 Employee Stock Purchase Plan. This sale was to cover tax liabilities in the vesting of RSUs. /s/ Jeffrey M. Held, Attorney-in-Fact 2023-10-31